<DOC>
	<DOCNO>NCT01996293</DOCNO>
	<brief_summary>This study seek examine dose lamotrigine ( Lamictal ) adjust pregnancy woman Bipolar Disorder . The investigator predict concentration Lamictal woman 's blood decrease pregnancy , increase postpartum . Because concentration medication likely decrease pregnancy , important doctor know much increase patient 's dose order prevent worsen Bipolar symptom . In study , investigator ask participant complete five overnight visit clinical research unit blood drawn every couple hour , IV catheter , measure concentration lamotrigine ( Lamictal ) change time . Participants compensate time .</brief_summary>
	<brief_title>Pregnant Women Taking Lamictal Bipolar Disorder</brief_title>
	<detailed_description>There increase risk recurrence Bipolar Disorder ( BD ) episodes worsen symptom pregnancy discontinuation mood stabilizer . Similarly , change medication concentration due physiological change pregnancy may effectively reduce medication dose thus efficacy pregnancy . Therapeutic dose monitoring proven great utility prevent seizure recurrence woman epilepsy ( WWE ) , specifically , dose monitoring lamotrigine ( LTG ) . Similar guideline woman epilepsy would benefit pregnant woman BD take lamotrigine ( LTG ) pregnancy . However , pharmacokinetics well utility therapeutic dose monitor LTG pregnant patient Bipolar Disorder well study . This study observational protocol explore longitudinal pharmacokinetics ( PK ) LTG pregnancy postpartum 10 woman Bipolar Disorder . The correlation change bioavailability level-to-dose ( L/D ) ratios increase symptom depression , mania anxiety recurrence syndromal BD episode fulfill Diagnostic Statistics Manual Mental Disorders ( IV ) ( DSM4 ) criterion investigate . The primary aim study 1 . ) To assess impact dynamic physiology pregnancy L/D ratio bioavailability LTG woman BD . 2 . ) To evaluate correlation maternal umbilical cord LTG serum level . 3 . ) To explore relationship decline LTG L/D ratio pregnancy , bioavailability increase psychiatric symptom recurrence syndromal BD . 4 . ) To explore relationship decline LTG L/D ratio pregnancy , bioavailability recurrence anxiety symptom . Additionally study evaluate correlation estradiol level change LTG L/D ratios pregnancy . To optimize research yield investigation , participant option allow banking cerebrospinal ( CSF ) fluid DNA future analysis .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Age 18 old If Pregnant , equal less 26 week Englishspeaking DSMIV Bipolar Disorder , subtype Able provide inform consent Daily dose Lamictal Active substance abuse within last 6 month and/or positive urine drug screen Active suicidality No obstetrical care Antiepileptic drug affect metabolism LTG Medications FDA category F X antimanic drug Liver kidney disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>pregnant</keyword>
	<keyword>bipolar</keyword>
	<keyword>lamotrigine</keyword>
	<keyword>lamictal</keyword>
	<keyword>woman</keyword>
	<keyword>female</keyword>
</DOC>